Phase II clinical trial of PM00104 (Zalypsis®) in urothelial carcinoma patients progressing after first-line platinum-based regimen

Author: Castellano Daniel   Bellmunt Joaquim   Maroto José   Font-Pous Albert   Morales-Barrera Rafael   Ghanem Ismael   Suarez Cristina   Martín Lorente Cristina   Etxaniz Olatz   Capdevila Laia   Coronado Cinthya   Alfaro Vicente   Siguero Mariano   Fernández-Teruel Carlos   Carles Joan  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.73, Iss.4, 2014-04, pp. : 857-867

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content